With the addition of uveitis Galapagos and Gilead are raising to 10 the number of indications in filgotinib&8217;s clinical pipeline. Galapagos and Gilead clearly have big expectations for filgotinib. The antibody isÂalready in Phase III for rheumatoid...
↧